CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,336 | -15.1% | 249 | -6.0% | 0.00% | – |
| Q2 2023 | $8,644 | -31.8% | 265 | -26.4% | 0.00% | – |
| Q1 2023 | $12,668 | -11.7% | 360 | +15.0% | 0.00% | – |
| Q4 2022 | $14,342 | +19.5% | 313 | +31.5% | 0.00% | – |
| Q3 2022 | $12,000 | +33.3% | 238 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 238 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 238 | +2.6% | 0.00% | – |
| Q4 2021 | $11,000 | +37.5% | 232 | +0.4% | 0.00% | – |
| Q3 2021 | $8,000 | +14.3% | 231 | -35.1% | 0.00% | – |
| Q2 2021 | $7,000 | -12.5% | 356 | +9.2% | 0.00% | – |
| Q1 2021 | $8,000 | – | 326 | +115.9% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 151 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | 0.0% | 151 | +42.5% | 0.00% | – |
| Q2 2013 | $1,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |